A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical

Authors

• Jaime Simon, IsoTherapeutics Group, LLCFollow
• Keith Frank, IsoTherapeutics Group, LLC
• Druce K. Crump, IsoTherapeutics Group, LLC
• William D. Erwin, The University of Texas MD Anderson Cancer Center
• Naoto T. Ueno, The University of Texas MD Anderson Cancer Center
• Richard E. Wendt PHD, University of MD Anderson Cancer CenterFollow

Files

Description

Simón J, Frank RK, Crump DK, Erwin WD, Ueno NT, Wendt RE. A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical. Nuclear Medicine and Biology. 2012/08/01/ 2012;39(6):770-776. doi:https://doi.org/10.1016/j.nucmedbio.2011.12.015

DOI

https://doi.org/10.1016/j.nucmedbio.2011.12.015

Publication Date

8-2012

Publisher

Elsevier ScienceDirect

Keywords

153Sm-DOTMPBone-seeking radiopharmaceuticalPreclinical study

Recommended Citation

Simon, Jaime; Frank, Keith; Crump, Druce K.; Erwin, William D.; Ueno, Naoto T.; and Wendt, Richard E. PHD, "A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical" (2012). Imaging Physics Journal Articles. 7.
doi:https://doi.org/10.1016/j.nucmedbio.2011.12.015